Release Date: 29/06/12 12:25 Summary: Appendix 3B - Correction to Option Expiry Date Price Sensitive: No Download Document 146.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%